Skip to main content
. 2016 Jun 10;27(9):1712–1718. doi: 10.1093/annonc/mdw227

Figure 1.

Figure 1.

Forest plots of risk difference and relative risk of select dermatologic adverse events of interest and diarrhea (all-causality, grade ≥2) in the first 8 weeks of treatment for the evaluable population of Cohort I placebo arm versus Cohort I doxycycline arm. The confidence interval is based on the Wald asymptomatic test with continuity correction. The reference arm is Cohort I placebo arm.